These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25613038)

  • 1. Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response?
    Palmerini E; Benassi MS; Quattrini I; Pazzaglia L; Donati D; Benini S; Gamberi G; Gambarotti M; Picci P; Ferrari S
    Orphanet J Rare Dis; 2015 Jan; 10():6. PubMed ID: 25613038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.
    ten Heuvel SE; Hoekstra HJ; Bastiaannet E; Suurmeijer AJ
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):189-95. PubMed ID: 18997619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of insulin-like growth factor-1 receptor in synovial sarcoma: association with an aggressive phenotype.
    Xie Y; Skytting B; Nilsson G; Brodin B; Larsson O
    Cancer Res; 1999 Aug; 59(15):3588-91. PubMed ID: 10446966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR‑494.3p expression in synovial sarcoma: Role of CXCR4 as a potential target gene.
    Pazzaglia L; Pollino S; Vitale M; Bientinesi E; Benini S; Ferrari C; Palmerini E; Gambarotti M; Picci P; Benassi MS
    Int J Oncol; 2019 Jan; 54(1):361-369. PubMed ID: 30431073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential roles of SS18-SSX fusion gene and insulin-like growth factor-1 receptor in synovial sarcoma cell growth.
    Törnkvist M; Natalishvili N; Xie Y; Girnita A; D'Arcy P; Brodin B; Axelson M; Girnita L
    Biochem Biophys Res Commun; 2008 Apr; 368(3):793-800. PubMed ID: 18267106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of TLE1, INI1, β-catenin, Claudin1, CK7, CK19, SS18 and calponin in synovial sarcoma.
    Madakshira MG; Radotra BD; Kaman L; Saikia UN
    Indian J Pathol Microbiol; 2021; 64(4):707-716. PubMed ID: 34673590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of expression of cancer stem cell markers and fusion gene in synovial sarcoma: Insights into histogenesis and pathogenesis.
    Zhou Y; Chen D; Qi Y; Liu R; Li S; Zou H; Lan J; Ju X; Jiang J; Liang W; Shen Y; Pang L; Li F
    Oncol Rep; 2017 Jun; 37(6):3351-3360. PubMed ID: 28498445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic impact of SYT-SSX fusion type and histological grade in pediatric patients with synovial sarcoma treated according to the CWS (Cooperative Weichteilsarkom Studie) trials.
    Stegmaier S; Leuschner I; Poremba C; Ladenstein R; Kazanowska B; Ljungman G; Scheer M; Blank B; Bielack S; Klingebiel T; Koscielniak E
    Pediatr Blood Cancer; 2017 Jan; 64(1):89-95. PubMed ID: 27621063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary synovial sarcoma of bone: a retrospective analysis of 25 patients.
    Righi A; Gambarotti M; Benini S; Gibertoni D; Asioli S; Magagnoli G; Gamberi G; Sbaraglia M; Cocchi S; Staals E; Palmerini E; Dei Tos AP
    Histopathology; 2022 Mar; 80(4):686-697. PubMed ID: 34821406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma.
    Amary MF; Berisha F; Bernardi Fdel C; Herbert A; James M; Reis-Filho JS; Fisher C; Nicholson AG; Tirabosco R; Diss TC; Flanagan AM
    Mod Pathol; 2007 Apr; 20(4):482-96. PubMed ID: 17334349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histology and grading are important prognostic factors in synovial sarcoma.
    Bianchi G; Sambri A; Righi A; Dei Tos AP; Picci P; Donati D
    Eur J Surg Oncol; 2017 Sep; 43(9):1733-1739. PubMed ID: 28579008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlating SS18-SSX immunohistochemistry (IHC) with SS18 fluorescent in situ hybridization (FISH) in synovial sarcomas: a study of 36 cases.
    Tay TKY; Sukma NB; Lim TH; Kuick CH; Goh JY; Chang KTE
    Virchows Arch; 2021 Oct; 479(4):785-793. PubMed ID: 34091760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When used together SS18-SSX fusion-specific and SSX C-terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in most cases.
    Zaborowski M; Vargas AC; Pulvers J; Clarkson A; de Guzman D; Sioson L; Maclean F; Chou A; Gill AJ
    Histopathology; 2020 Oct; 77(4):588-600. PubMed ID: 32559341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
    Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
    Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary pleuropulmonary and mediastinal synovial sarcoma: a clinicopathologic and molecular study of 26 genetically confirmed cases in the largest institution of southwest China.
    Lan T; Chen H; Xiong B; Zhou T; Peng R; Chen M; Ye F; Yao J; He X; Wang Y; Zhang H
    Diagn Pathol; 2016 Jul; 11(1):62. PubMed ID: 27401493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer.
    Agulló-Ortuño MT; Díaz-García CV; Agudo-López A; Pérez C; Cortijo A; Paz-Ares L; López-Ríos F; Pozo F; de Castro J; Cortés-Funes H; López Martín JA
    J Cancer Res Clin Oncol; 2015 Jan; 141(1):43-53. PubMed ID: 25081930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
    Friedrichs N; Küchler J; Endl E; Koch A; Czerwitzki J; Wurst P; Metzger D; Schulte JH; Holst MI; Heukamp LC; Larsson O; Tanaka S; Kawai A; Wardelmann E; Buettner R; Pietsch T; Hartmann W
    J Pathol; 2008 Dec; 216(4):428-39. PubMed ID: 18855347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel SS18-SSX Fusion-specific Antibody for the Diagnosis of Synovial Sarcoma.
    Baranov E; McBride MJ; Bellizzi AM; Ligon AH; Fletcher CDM; Kadoch C; Hornick JL
    Am J Surg Pathol; 2020 Jul; 44(7):922-933. PubMed ID: 32141887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas.
    Asmane I; Watkin E; Alberti L; Duc A; Marec-Berard P; Ray-Coquard I; Cassier P; Decouvelaere AV; Ranchère D; Kurtz JE; Bergerat JP; Blay JY
    Eur J Cancer; 2012 Nov; 48(16):3027-35. PubMed ID: 22682017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases.
    Przybyl J; Sciot R; Rutkowski P; Siedlecki JA; Vanspauwen V; Samson I; Debiec-Rychter M
    Tumour Biol; 2012 Dec; 33(6):2245-53. PubMed ID: 22976541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.